Orfit Industries, naamloze vennootschap – Trademark Portfolio
Entity Type: 99
Orfit Industries, naamloze vennootschap holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 17 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include UON, DUON, ORFIT, MAMMORX, and MULTIFIT NS. The owner is based in Wijnegem.
Vosveld 9a
Wijnegem 2110 , BE
Showing of trademarks Trademarks
Trademark Classifications
Orfit Industries, naamloze vennootschap's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Orfit Industries, naamloze vennootschap have?
Orfit Industries, naamloze vennootschap has 17 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 cancelled.
What trademark classes does Orfit Industries, naamloze vennootschap file in?
Orfit Industries, naamloze vennootschap files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 17 (Rubber Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Orfit Industries, naamloze vennootschap's most well-known trademarks?
Orfit Industries, naamloze vennootschap's registered trademark portfolio includes well-known marks such as UON, DUON, ORFIT, MAMMORX, and MULTIFIT NS. These are among 6 currently registered trademarks in the portfolio.
What is Orfit Industries, naamloze vennootschap's trademark registration success rate?
Orfit Industries, naamloze vennootschap has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.